Skip to content
Polis

House bill · 89R

HB 1680

Relating to prior authorization for prescription drug benefits related to the prevention of human immunodeficiency virus infections.

Did not pass

Progress

144 days from first to latest action, across 13 recorded actions.

  1. Filed

    Dec 19

  2. Referred to committee

    Mar 12

  3. Heard in committee

    May 7

  4. Reported from committee

    May 9

  5. Passed first chamber

    Stopped here

  6. Passed second chamber

  7. Sent to governor

  8. Became law

HouseJanFebMarAprMay

Filled marks are milestones (committee report, floor passage, governor action). Larger marks hold more same-day actions.

Full history

Every action recorded by Texas Legislature Online.

  1. Committee report sent to Calendars

    May 12, 2025 · House

  2. Committee report distributed

    May 12, 2025 · House

  3. Comte report filed with Committee Coordinator

    May 12, 2025 · House

  4. Reported favorably w/o amendment(s) Insurance

    May 9, 2025 · House

  5. Considered in formal meeting

    May 9, 2025 · House

  6. Failed to receive affirmative vote in comm. Insurance

    May 7, 2025 · House

  7. Considered in formal meeting

    May 7, 2025 · House

  8. Left pending in committee

    May 7, 2025 · House

  9. Testimony taken/registration(s) recorded in committee Insurance

    May 7, 2025 · House

  10. Considered in public hearing Insurance

    May 7, 2025 · House

  11. Referred to Insurance Insurance

    Mar 12, 2025 · House

  12. Read first time

    Mar 12, 2025 · House

  13. Filed

    Dec 19, 2024 · House

Authors

In committee

  • Insurance

    House

    Referred Mar 12, 2025 · heard May 7, 2025 · reported after 58 days

Topics

Bill text

Bills on similar topics

Other legislation this session sharing the most index topics.

HB 1680 (89R) · Polis